Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment

SIMPLE SUMMARY: The use of neoadjuvant therapy (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) is increasing. Objective quantification of the histopathological response to NAT may be used to guide adjuvant treatment and compare the efficacy of neoadjuvant regimens. However, current tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Boris V., Theijse, Rutger, van Roessel, Stijn, de Ruiter, Rik, Berkel, Antonie, Huiskens, Joost, Busch, Olivier R., Wilmink, Johanna W., Kazemier, Geert, Valkema, Pieter, Farina, Arantza, Verheij, Joanne, de Boer, Onno J., Besselink, Marc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533716/
https://www.ncbi.nlm.nih.gov/pubmed/34680241
http://dx.doi.org/10.3390/cancers13205089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533716/
https://www.ncbi.nlm.nih.gov/pubmed/34680241
http://dx.doi.org/10.3390/cancers13205089

Ejemplares similares